AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33441871 — intervention group
Group type: EXPERIMENTAL
Intervention: Cluster analysis based on EST-SSR data.
Number of subjects: 60
Study 33092565 — intervention group
Group type: EXPERIMENTAL
Intervention: Upgraded Maternity Waiting Homes (MWHs) combined with local leader training on safe motherhood strategies
Number of subjects: 7593
Study 33092565 — intervention group
Group type: EXPERIMENTAL
Intervention: Local leader training only
Number of subjects: 7593
Study 33092565 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 7593
Study 34498987 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive training for four weeks
Number of subjects: 0
Study 34498987 — intervention group
Group type: COMPARATOR
Intervention: Control group received lectures on health and aging
Number of subjects: 0
Study 34620410 — intervention group
Group type: EXPERIMENTAL
Intervention: Icosapent ethyl (IPE)
Number of subjects: 8179
Study 34620410 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8179
Study 35941573 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum probiotic (6 × 1010 CFUs) for 16 weeks
Number of subjects: 35
Study 35941573 — intervention group
Group type: COMPARATOR
Intervention: Placebo for 16 weeks
Number of subjects: 35
Study 33545574 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Da-Cheng-Qi Decoction (CDCQD), 100 ml twice a day for 7 days
Number of subjects: 30
Study 33545574 — intervention group
Group type: COMPARATOR
Intervention: Plain boiled water (Control)
Number of subjects: 30
Study 33545574 — intervention group
Group type: EXPERIMENTAL
Intervention: Compound Da-Cheng-Qi Decoction (CDCQD)
Number of subjects: 30
Study 33713247 — intervention group
Group type: EXPERIMENTAL
Intervention: 12-miRNA signature identified through NanoString nCounter miRNA assay
Number of subjects: 24
Study 33713247 — intervention group
Group type: EXPERIMENTAL
Intervention: miRNA profiling
Number of subjects: 24
Study 34000227 — intervention group
Group type: EXPERIMENTAL
Intervention: Islatravir 0.25 mg + doravirine (100 mg) + lamivudine (300 mg)
Number of subjects: 121
Study 34000227 — intervention group
Group type: EXPERIMENTAL
Intervention: Islatravir 0.75 mg + doravirine (100 mg) + lamivudine (300 mg)
Number of subjects: 121
Study 34000227 — intervention group
Group type: EXPERIMENTAL
Intervention: Islatravir 2.25 mg + doravirine (100 mg) + lamivudine (300 mg)
Number of subjects: 121
Study 34000227 — intervention group
Group type: COMPARATOR
Intervention: Doravirine (100 mg) + lamivudine (300 mg) + TDF (300 mg)
Number of subjects: 121
Study 34000227 — intervention group
Group type: EXPERIMENTAL
Intervention: All islatravir groups combined
Number of subjects: 121
Study 34000227 — intervention group
Group type: COMPARATOR
Intervention: Doravirine + lamivudine + TDF group
Number of subjects: 121
Study 34000227 — intervention group
Group type: EXPERIMENTAL
Intervention: Islatravir 2.25 mg group
Number of subjects: 121
Study 36045091 — intervention group
Group type: EXPERIMENTAL
Intervention: Promoting healthier products on the Sainsbury's online supermarket platform
Number of subjects: 0
Study 36045091 — intervention group
Group type: COMPARATOR
Intervention: Control arm (standard products)
Number of subjects: 0
Study 36045091 — intervention group
Group type: EXPERIMENTAL
Intervention: Banner clicks
Number of subjects: 0
Study 36045091 — intervention group
Group type: EXPERIMENTAL
Intervention: Energy purchased
Number of subjects: 0
Study 32985991 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital app guidance for exercise (AP group)
Number of subjects: 54
Study 32985991 — intervention group
Group type: COMPARATOR
Intervention: Physiotherapist guidance for exercise (PA group)
Number of subjects: 54
Study 32962477 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide therapy
Number of subjects: 25
Study 32962477 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 25
Study 33929379 — intervention group
Group type: EXPERIMENTAL
Intervention: Induction infliximab therapy
Number of subjects: 421
Study 33266002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa and dark chocolate intake
Number of subjects: 0
Study 33266002 — intervention group
Group type: EXPERIMENTAL
Intervention: Cocoa polyphenols
Number of subjects: 0
Study 35836627 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of injection terlipressin 0.02 µg/kg/min infusion and injection norepinephrine 0.01 µg/kg/min infusion
Number of subjects: 50
Study 35836627 — intervention group
Group type: COMPARATOR
Intervention: Norepinephrine 0.01 µg/kg/min infusion alone
Number of subjects: 50
Study 35836627 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of injection terlipressin and norepinephrine
Number of subjects: 50
Study 33728989 — intervention group
Group type: EXPERIMENTAL
Intervention: HOPE (intervention)
Number of subjects: 225
Study 33020137 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression (ASD)
Number of subjects: 210
Study 33020137 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic arthroscopy
Number of subjects: 210
Study 33020137 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 210
Study 37301833 — intervention group
Group type: EXPERIMENTAL
Intervention: COVID-19 period (n=542)
Number of subjects: 1072
Study 33097306 — intervention group
Group type: EXPERIMENTAL
Intervention: Bio-electrical impedance vector analysis (BIVA)
Number of subjects: 183
Study 32021090 — intervention group
Group type: EXPERIMENTAL
Intervention: SB4 autoinjector (AI)
Number of subjects: 50
Study 32021090 — intervention group
Group type: COMPARATOR
Intervention: SB4 pre-filled syringe (PFS)
Number of subjects: 50
Study 34224671 — intervention group
Group type: EXPERIMENTAL
Intervention: GP-led care
Number of subjects: 303
Study 34224671 — intervention group
Group type: COMPARATOR
Intervention: Surgeon-led care
Number of subjects: 303
Study 34224671 — intervention group
Group type: EXPERIMENTAL
Intervention: GP-led care with Oncokompas
Number of subjects: 303
Study 34224671 — intervention group
Group type: COMPARATOR
Intervention: Surgeon-led care with Oncokompas
Number of subjects: 303
Study 32381418 — intervention group
Group type: EXPERIMENTAL
Intervention: Mineral Trioxide Aggregate
Number of subjects: 0
Study 32381418 — intervention group
Group type: COMPARATOR
Intervention: Calcium Hydroxide
Number of subjects: 0
Study 35996199 — intervention group
Group type: EXPERIMENTAL
Intervention: TQG202 prophylaxis (30 ± 5 IU/kg initial dose for 24 weeks)
Number of subjects: 81
Study 33920292 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine (2 × 2.5 mg/kg/24 h)
Number of subjects: 37
Study 33920292 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 33920292 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeine
Number of subjects: 37
Study 32652314 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injections (IAIs) 2 mg every 4 weeks
Number of subjects: 1804
Study 32652314 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept injections (IAIs) 2 mg every 8 weeks after 3 initial monthly doses
Number of subjects: 1804
Study 32652314 — intervention group
Group type: EXPERIMENTAL
Intervention: Ranibizumab every 4 weeks
Number of subjects: 1804
Study 32652314 — intervention group
Group type: COMPARATOR
Intervention: Eyes with predominantly classic CNV
Number of subjects: 1804
Study 32652314 — intervention group
Group type: EXPERIMENTAL
Intervention: Eyes with occult CNV
Number of subjects: 1804
Study 32610495 — intervention group
Group type: EXPERIMENTAL
Intervention: Lactobacillus plantarum DR7
Number of subjects: 0
Study 32610495 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 35032906 — intervention group
Group type: EXPERIMENTAL
Intervention: Lurasidone (20-80 mg/day)
Number of subjects: 271
Study 34333555 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketamine
Number of subjects: 21
Study 34333555 — intervention group
Group type: COMPARATOR
Intervention: Midazolam
Number of subjects: 21
Study 32320100 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (preoperative education, postoperative abdominal massage, and polyethylene glycol 4,000)
Number of subjects: 80
Study 32320100 — intervention group
Group type: COMPARATOR
Intervention: Preoperative education only
Number of subjects: 80
Study 32320100 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment and Preoperative education only
Number of subjects: 80
Study 33583000 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention (individual nutrition counseling) aiming for daily protein intake of 1.0-1.2 g/kg body weight, energy intake of 25-30 kcal/kg body weight/day, and serum vitamin D concentration ≥ 75 mmol/L
Number of subjects: 1517
Study 33583000 — intervention group
Group type: EXPERIMENTAL
Intervention: Nutrition intervention (individual nutrition counseling)
Number of subjects: 1517
Study 32067684 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental induction chemotherapy with two additional courses of topotecan, cyclophosphamide, and etoposide followed by standard induction chemotherapy (eight courses in total)
Number of subjects: 536
Study 32067684 — intervention group
Group type: COMPARATOR
Intervention: Standard induction therapy with six chemotherapy courses
Number of subjects: 536
Study 32067684 — intervention group
Group type: EXPERIMENTAL
Intervention: Experimental induction chemotherapy with two additional courses of topotecan, cyclophosphamide, and etoposide followed by standard induction chemotherapy
Number of subjects: 536
Study 35162608 — intervention group
Group type: EXPERIMENTAL
Intervention: Tailored fall‐prevention program in addition to usual care
Number of subjects: 72
Study 35162608 — intervention group
Group type: COMPARATOR
Intervention: Standard care (exercise to prevent recurrent falls)
Number of subjects: 72
Study 34656952 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin roasted peanuts (SRP, 25 g/day)
Number of subjects: 63
Study 34656952 — intervention group
Group type: EXPERIMENTAL
Intervention: Peanut butter (PB, 32 g/day)
Number of subjects: 63
Study 34656952 — intervention group
Group type: COMPARATOR
Intervention: Control butter (CB, 32 g/day)
Number of subjects: 63
Study 34077818 — intervention group
Group type: EXPERIMENTAL
Intervention: Adapted docetaxel regimen
Number of subjects: 325
Study 34077818 — intervention group
Group type: COMPARATOR
Intervention: Standard docetaxel regimen
Number of subjects: 325
Study 34077818 — intervention group
Group type: EXPERIMENTAL
Intervention: Dose reduction of docetaxel
Number of subjects: 325
Study 32299247 — intervention group
Group type: EXPERIMENTAL
Intervention: CBT‐Meno
Number of subjects: 36
Study 32299247 — intervention group
Group type: COMPARATOR
Intervention: Waitlist
Number of subjects: 36
Study 34278653 — intervention group
Group type: EXPERIMENTAL
Intervention: Dove Real Beauty ID video
Number of subjects: 568
Study 34278653 — intervention group
Group type: COMPARATOR
Intervention: Control video
Number of subjects: 568
Study 34155987 — intervention group
Group type: EXPERIMENTAL
Intervention: Main group with dysbiosis and hormonal imbalance
Number of subjects: 90
Study 34155987 — intervention group
Group type: COMPARATOR
Intervention: Control group with significant number of lactobacilli
Number of subjects: 90
Study 36735400 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg daily for 12 months)
Number of subjects: 252
Study 36735400 — intervention group
Group type: COMPARATOR
Intervention: Placebo (once daily for 12 months)
Number of subjects: 252
Study 33382436 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-Care Ability (SCA) intervention
Number of subjects: 170
Study 33382436 — intervention group
Group type: EXPERIMENTAL
Intervention: Loneliness assessment
Number of subjects: 170
Study 33382436 — intervention group
Group type: EXPERIMENTAL
Intervention: Social isolation assessment
Number of subjects: 170
Study 32527268 — intervention group
Group type: EXPERIMENTAL
Intervention: Real dual‐tDCS (2 mA for 20 mins) with concurrent paretic hand exercise
Number of subjects: 18
Study 32527268 — intervention group
Group type: COMPARATOR
Intervention: Sham dual‐tDCS
Number of subjects: 18
Study 36273181 — intervention group
Group type: EXPERIMENTAL
Intervention: Jiu‐Wei‐Xi‐Feng granules (Os Draconis replaced by Concha Ostreae) (JWXFD)
Number of subjects: 288
Study 36273181 — intervention group
Group type: COMPARATOR
Intervention: Jiu‐Wei‐Xi‐Feng granules (original formula) (JWXFO)
Number of subjects: 288
Study 36273181 — intervention group
Group type: EXPERIMENTAL
Intervention: JWXFD
Number of subjects: 288
Study 34294808 — intervention group
Group type: EXPERIMENTAL
Intervention: NK cells with K562 tumor cells
Number of subjects: 0
Study 34294808 — intervention group
Group type: EXPERIMENTAL
Intervention: NK cells with IL-15-secreting variant of K562 tumor cells
Number of subjects: 0
Study 34294808 — intervention group
Group type: COMPARATOR
Intervention: NK cells without tumor cells
Number of subjects: 0
Study 32466854 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin D3 50,000-unit pearl weekly for 4 weeks prior to the operation
Number of subjects: 100
Study 32466854 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 36056401 — intervention group
Group type: EXPERIMENTAL
Intervention: Mindfulness and compassion-focused program
Number of subjects: 72
Study 34653566 — intervention group
Group type: EXPERIMENTAL
Intervention: Intelligent insole system with pressure-sensing insoles and digital watch, worn during all daily activity for 18 months.
Number of subjects: 46
Study 34653566 — intervention group
Group type: COMPARATOR
Intervention: Control group (CG) without the intelligent insole system.
Number of subjects: 46
Study 33136871 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical Procedure A (Carstens' variant with modifications)
Number of subjects: 291
Study 33136871 — intervention group
Group type: COMPARATOR
Intervention: Surgical Procedure B
Number of subjects: 291
Study 35560498 — intervention group
Group type: EXPERIMENTAL
Intervention: HEAT
Number of subjects: 31
Study 35560498 — intervention group
Group type: EXPERIMENTAL
Intervention: EX
Number of subjects: 31
Study 35560498 — intervention group
Group type: COMPARATOR
Intervention: CON
Number of subjects: 31
Study 32980772 — intervention group
Group type: EXPERIMENTAL
Intervention: 20-Hz repetitive transcranial magnetic stimulation
Number of subjects: 52
Study 32980772 — intervention group
Group type: COMPARATOR
Intervention: Sham stimulation
Number of subjects: 52
Study 616744333 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitamin B1 and B2 levels in ICP patients (Group 1)
Number of subjects: 75
Study 616744333 — intervention group
Group type: EXPERIMENTAL
Intervention: Total cholesterol levels in ICP patients (Group 1)
Number of subjects: 75
Study 616744333 — intervention group
Group type: EXPERIMENTAL
Intervention: LDL levels in ICP patients (Group 1)
Number of subjects: 75
Study 616744333 — intervention group
Group type: EXPERIMENTAL
Intervention: HDL levels in ICP patients (Group 1)
Number of subjects: 75
Study 616744333 — intervention group
Group type: COMPARATOR
Intervention: Triglycerides (TG) levels in ICP patients (Group 1)
Number of subjects: 75
Study 35193445 — intervention group
Group type: EXPERIMENTAL
Intervention: Intensive physiotherapy (twice-daily)
Number of subjects: 40
Study 35193445 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy (once-daily)
Number of subjects: 40
Study 33433575 — intervention group
Group type: EXPERIMENTAL
Intervention: 45 mg sodium nitrite
Number of subjects: 1502
Study 33433575 — intervention group
Group type: EXPERIMENTAL
Intervention: 60 mg sodium nitrite
Number of subjects: 1502
Study 33433575 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1502
Study 32689969 — intervention group
Group type: EXPERIMENTAL
Intervention: Half-Perc technique
Number of subjects: 240
Study 36104235 — intervention group
Group type: EXPERIMENTAL
Intervention: 25 mg/day of empagliflozin
Number of subjects: 100
Study 36104235 — intervention group
Group type: COMPARATOR
Intervention: 10 mg/day of empagliflozin
Number of subjects: 100
Study 33097945 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 35% V̇O2 peak
Number of subjects: 9
Study 33097945 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 50% V̇O2 peak
Number of subjects: 9
Study 33097945 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 65% V̇O2 peak
Number of subjects: 9
Study 33097945 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise at 80% V̇O2 peak
Number of subjects: 9
Study 33097945 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exercise at 65% V̇O2 peak
Number of subjects: 9
Study 33097945 — intervention group
Group type: EXPERIMENTAL
Intervention: Post-exercise at 80% V̇O2 peak
Number of subjects: 9
Study 32475246 — intervention group
Group type: EXPERIMENTAL
Intervention: GTS stem
Number of subjects: 50
Study 32475246 — intervention group
Group type: COMPARATOR
Intervention: Taperloc stem
Number of subjects: 50
Study 33901728 — intervention group
Group type: EXPERIMENTAL
Intervention: Training workshop on early recognition and care for toddlers with ASD and use of webM-CHAT-R/F
Number of subjects: 46
Study 33009281 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical bromfenac (Yellox)
Number of subjects: 722
Study 33009281 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical dexamethasone
Number of subjects: 722
Study 33009281 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination treatment (bromfenac and dexamethasone)
Number of subjects: 722
Study 32138641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion at 15 °C (CW15)
Number of subjects: 29
Study 32138641 — intervention group
Group type: EXPERIMENTAL
Intervention: Cold water immersion at 8 °C (CW8)
Number of subjects: 29
Study 32138641 — intervention group
Group type: COMPARATOR
Intervention: Passive recovery (PAS)
Number of subjects: 29
Study 32819209 — intervention group
Group type: EXPERIMENTAL
Intervention: Large poster depicting a natural woodland scene
Number of subjects: 0
Study 32819209 — intervention group
Group type: COMPARATOR
Intervention: No poster (control condition)
Number of subjects: 0
Study 33150227 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV/AIDS knowledge assessment through a self‐administered questionnaire
Number of subjects: 200
Study 36126605 — intervention group
Group type: EXPERIMENTAL
Intervention: Cetuximab plus radiotherapy (cet+RT)
Number of subjects: 407
Study 36126605 — intervention group
Group type: COMPARATOR
Intervention: Cisplatin plus radiotherapy (cis+RT)
Number of subjects: 407
Study 32914276 — intervention group
Group type: EXPERIMENTAL
Intervention: EDOF Tecnis Symfony (ZXR00) IOL
Number of subjects: 29
Study 32914276 — intervention group
Group type: COMPARATOR
Intervention: Diffractive multifocal Tecnis + 2.75 D (ZKB00) IOL
Number of subjects: 29
Study 36029467 — intervention group
Group type: EXPERIMENTAL
Intervention: Dapagliflozin
Number of subjects: 6263
Study 36029467 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6263
Study 33448029 — intervention group
Group type: EXPERIMENTAL
Intervention: Depot medroxyprogesterone acetate (DMPA‐IM)
Number of subjects: 605
Study 33448029 — intervention group
Group type: COMPARATOR
Intervention: Copper intrauterine device (IUD)
Number of subjects: 605
Study 33448029 — intervention group
Group type: COMPARATOR
Intervention: Levonorgestrel (LNG) implant
Number of subjects: 605
Study 33058961 — intervention group
Group type: EXPERIMENTAL
Intervention: BMI > 30
Number of subjects: 5623
Study 33058961 — intervention group
Group type: EXPERIMENTAL
Intervention: Per log ng/mL higher serum leptin
Number of subjects: 5623
Study 33058961 — intervention group
Group type: COMPARATOR
Intervention: Reference BMI (BMI 18−25 kg/m2)
Number of subjects: 5623
Study 35567859 — intervention group
Group type: EXPERIMENTAL
Intervention: Daily 100 mg aspirin
Number of subjects: 19114
Study 35567859 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 19114
Study 34764381 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled bloodlettings
Number of subjects: 33
Study 34764381 — intervention group
Group type: COMPARATOR
Intervention: Observation (Control)
Number of subjects: 33
Study 34764381 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined oral contraceptives (COC)
Number of subjects: 33
Study 33381574 — intervention group
Group type: EXPERIMENTAL
Intervention: Developed insoles with a toe-grip bar
Number of subjects: 12
Study 33381574 — intervention group
Group type: COMPARATOR
Intervention: General insoles
Number of subjects: 12
Study 35552971 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33459517 — intervention group
Group type: EXPERIMENTAL
Intervention: Operating room noise levels
Number of subjects: 92
Study 33459517 — intervention group
Group type: EXPERIMENTAL
Intervention: Physiological effects of noise
Number of subjects: 92
Study 33459517 — intervention group
Group type: EXPERIMENTAL
Intervention: Psychological effects of noise
Number of subjects: 92
Study 33459517 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall effects of noise
Number of subjects: 92
Study 33459517 — intervention group
Group type: EXPERIMENTAL
Intervention: Noise disturbance score
Number of subjects: 92
Study 33459517 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-affected staff
Number of subjects: 92
Study 36249182 — intervention group
Group type: EXPERIMENTAL
Intervention: Digital physiotherapy intervention through an app on a recycled mobile device for 4 weeks
Number of subjects: 60
Study 36249182 — intervention group
Group type: COMPARATOR
Intervention: Standard physiotherapy care recommended for patients discharged from the hospital
Number of subjects: 60
Study 33849097 — intervention group
Group type: EXPERIMENTAL
Intervention: Multi-dimensional postpartum visits (MDPV)
Number of subjects: 114
Study 33849097 — intervention group
Group type: COMPARATOR
Intervention: Routine postpartum visits (Control)
Number of subjects: 114
Study 34807249 — intervention group
Group type: EXPERIMENTAL
Intervention: Treatment group informed about 17 Japanese family policy benefits
Number of subjects: 0
Study 34807249 — intervention group
Group type: COMPARATOR
Intervention: Control group with no information exposure
Number of subjects: 0
Study 32073874 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 mL V. odorata syrup every 12 hours for 4 weeks
Number of subjects: 83
Study 32073874 — intervention group
Group type: COMPARATOR
Intervention: 5 mL placebo syrup every 12 hours for 4 weeks
Number of subjects: 83
Study 35915032 — intervention group
Group type: EXPERIMENTAL
Intervention: Real-time visualization of CPR activity on a feedback device (Group C)
Number of subjects: 46
Study 35915032 — intervention group
Group type: EXPERIMENTAL
Intervention: CPR checklist (Group B)
Number of subjects: 46
Study 35915032 — intervention group
Group type: COMPARATOR
Intervention: No performance aid (Group A)
Number of subjects: 46